A recent study in Shh medulloblastoma, a pediatric brain tumor characterized by aberrant activation of the Shh signaling, provided further evidence that biguanides can target the transcriptional activity downstream of the Shh pathway. The gene discussed is SHH; the disease is brain neoplasm.